Last reviewed · How we verify

NCT07321990: mSMAFRS-F

Study of the Reproducibility of the French Version of the Modified SMAFRS Scale

Recruiting now Last updated 7 January 2026
What this trial tests

trial testing Questionnaire and Physical Exam in SMA in 60 participants. Currently enrolling.

Timeline
18 July 2025
Primary endpoint
31 October 2026
31 October 2026

Quick facts

Lead sponsorInstitut de Myologie, France
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment60
Start date18 July 2025
Primary completion31 October 2026
Estimated completion31 October 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Institut de Myologie, France — full company profile →

Who can join

Under 18, any sex, with SMA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to evaluate the test-retest reliability of the French version of the mSMAFRS in adult patients with SMA. The main question\[s\] is to answer if: * ICC is a good estimate of test-retest reliability? * mSMAFRS-F correlate with other outcome measures? Participants will simply answer a french version of the SMA-FRS questionnaire during their routine follow-up visit then again fifteen days later.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire and Physical Exam

Trials testing the same drug.

Other recruiting trials for SMA

Currently open trials in the same condition.

Other Institut de Myologie, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07321990.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing